Table II.
Comparison of the surviving and deceased groups for continuous (quantitative) variables
| Outcome | Surviving | Deceased | Total | P-value |
|---|---|---|---|---|
| Age | 58.57 ±14.33 | 70.96 ±11.39 | 61.63 ±14.63 | 0.001 |
| Hb | 12.38 ±2.23 | 10.59 ±1.73 | 11.97 ±2.25 | 0.001 |
| Neutrophils (%) | 68.22 ±10.43 | 71.77 ±12.39 | 69.03 ±10.95 | 0.201 |
| Lymphocytes/neutrophils | 0.36 ±0.20 | 0.29 ±0.22 | 0.35 ±0.20 | 0.166 |
| Lymphocytes (%) | 23 (82–5) | 17 (42–4) | 22 (82–4) | 0.086 |
| Hospital stay [days] | 8 (29–3) | 7 (29–3) | 8 (29–3) | 0.862 |
| Tumor size [mm] | 40 (190–4) | 55 (110–25) | 45 (190–4) | 0.203 |
| T stage | 3 (4–0) | 3 (4–0) | 3 (4–0) | 0.058 |
| N (total) | 12 (72–1) | 18 (45–4) | 14.5 (72–1) | 0.159 |
| N(+) | 0 (13–0) | 1 (44–0) | 0 (44–0) | 0.009 |
| N(+)/total N | 0 (0.75–0) | 0.08 (0.98–0) | 0 (0.98–0) | 0.012 |
| Thrombocytes (× 103) | 290 (968–144.7) | 345.85 (607–71) | 298.8 (968–71) | 0.047 |
| WBC | 8305 (18670–3480) | 9570 (16760–4520) | 8330 (18670–3480) | 0.299 |
| RDW% | 16 (33–4) | 17 (23–13) | 16 (33–4) | 0.073 |
| PDW | 43.45 (71.7–16.05) | 44.4 (56.8–15.82) | 43.9 (71.7–15.82) | 0.988 |